Trimedyne Shares Resume Nasdaq Trading
- Share via
Trimedyne Inc.’s stock is trading again after an interruption in market activity that the company blamed on a “clerical error.”
Nasdaq market officials halted trading of the medical laser designer’s shares Friday. Trimedyne said that was because Nasdaq was awaiting proof that the company has a valid Nevada corporate charter.
Trimedyne was late in getting that information to Nasdaq because the company’s corporate charter had temporarily lapsed when a form was not filled with the state on time, Trimedyne said.
Trimedyne’s stock closed unchanged Wednesday at 94 cents.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
